News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,038 Results
Type
Article (2148)
Company Profile (5)
Press Release (26885)
Section
Business (7456)
Career Advice (189)
Deals (1160)
Drug Delivery (5)
Drug Development (1896)
Employer Resources (7)
FDA (848)
Job Trends (650)
News (11737)
Policy (970)
Tag
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
Academia (198)
Adcomms (1)
Allergies (1)
Alliances (1884)
ALS (6)
Alzheimer's disease (42)
Antibody-drug conjugate (ADC) (2)
Approvals (845)
Artificial intelligence (12)
Automation (2)
Bankruptcy (8)
Best Places to Work (519)
Biosimilars (2)
Biotechnology (3)
Breast cancer (5)
Cancer (67)
Cardiovascular disease (6)
Career advice (164)
Career pathing (2)
CAR-T (3)
Cell therapy (7)
Clinical research (1517)
Collaboration (31)
Compensation (9)
Complete response letters (1)
COVID-19 (71)
C-suite (4)
Data (53)
Depression (4)
Diabetes (14)
Diagnostics (176)
Digital health (1)
Drug discovery (3)
Drug pricing (2)
Drug shortages (2)
Earnings (2202)
Editorial (2)
Employer branding (1)
Employer resources (6)
Events (3084)
Executive appointments (19)
FDA (882)
Featured Employer (3)
Frontotemporal dementia (1)
Funding (22)
Generative AI (1)
Gene therapy (5)
GLP-1 (51)
Government (160)
Guidances (2)
Healthcare (624)
Infectious disease (73)
Inflammatory bowel disease (2)
Influenza (1)
Intellectual property (3)
Interviews (37)
IPO (434)
Job creations (143)
Job search strategy (142)
Labor market (1)
Layoffs (9)
Leadership (2)
Legal (225)
Liver cancer (5)
Lung cancer (6)
Lymphoma (8)
Machine learning (1)
Management (4)
Manufacturing (16)
MASH (2)
Medical device (1023)
Medtech (1023)
Mergers & acquisitions (745)
Metabolic disorders (47)
Multiple sclerosis (2)
Neurodegenerative disease (2)
Neuroscience (62)
NextGen: Class of 2025 (415)
Non-profit (266)
Northern California (87)
Obesity (31)
Opinion (11)
Ovarian cancer (3)
Pain (3)
Pancreatic cancer (6)
Parkinson's disease (3)
Partnered (1)
Patents (5)
People (2523)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (443)
Phase II (671)
Phase III (497)
Pipeline (22)
Postmarket research (64)
Preclinical (243)
Press Release (5)
Prostate cancer (10)
Radiopharmaceuticals (23)
Rare diseases (8)
Real estate (361)
Recruiting (2)
Regulatory (641)
Reports (1)
Research institute (159)
Resumes & cover letters (24)
Schizophrenia (2)
Series A (6)
Sickle cell disease (2)
Southern California (37)
Spinal muscular atrophy (8)
Sponsored (1)
Startups (219)
Stomach cancer (1)
Supply chain (3)
United States (654)
Vaccines (12)
Weight loss (10)
Worklife (2)
Date
Today (4)
Last 7 days (19)
Last 30 days (92)
Last 365 days (1084)
2025 (244)
2024 (1155)
2023 (1419)
2022 (3684)
2021 (2439)
2020 (1868)
2019 (2163)
2018 (1668)
2017 (1271)
2016 (1397)
2015 (1831)
2014 (1380)
2013 (1294)
2012 (1322)
2011 (1360)
2010 (1026)
Location
Africa (56)
Alaska (1)
Arizona (4)
Asia (1685)
Australia (225)
California (149)
Canada (46)
China (11)
Colorado (5)
Europe (3505)
Florida (36)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (7)
Japan (7)
Kansas (4)
Maryland (27)
Massachusetts (101)
Michigan (27)
Minnesota (29)
Missouri (2)
Nevada (1)
New Hampshire (1)
New Jersey (52)
New York (43)
North Carolina (36)
North Dakota (1)
Northern California (87)
Ohio (20)
Oklahoma (1)
Oregon (2)
Pennsylvania (20)
Rhode Island (2)
South America (88)
South Carolina (1)
Southern California (37)
Tennessee (1)
Texas (38)
Utah (10)
Virginia (5)
Washington State (11)
West Virginia (1)
Wisconsin (8)
29,038 Results for "sapphire energy".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 17, 2025
·
13 min read
Press Releases
Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
February 21, 2025
·
9 min read
Press Releases
Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
October 7, 2024
·
13 min read
Press Releases
MATELASER Introduces X1 Performance: The Ultimate Portable High-Energy Laser Therapy System for Pain Management
March 13, 2025
·
3 min read
Press Releases
Addis Energy Introduces Novel Technology to Unleash the Earth’s Potential for Clean Ammonia Production
January 21, 2025
·
5 min read
Press Releases
Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter
January 10, 2025
·
10 min read
Biotech Beach
Bitech Technologies Receives Initial Purchase Order for its Innovative Energy-Saving VPP Solution to Enter the Building Energy Management System (BEMS) Market
Bitech Technologies Corporation is pleased to announce the launch of its previously announced initiative to enter into the Building Energy Management System business.
January 5, 2024
·
8 min read
Drug Development
Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
Scholar Rock announced today that it has completed enrollment of the SAPPHIRE Phase 3 trial evaluating the safety and efficacy of apitegromab in nonambulatory patients with Types 2 and 3 spinal muscular atrophy (SMA) who are receiving SMN therapy (either nusinersen or risdiplam).
September 19, 2023
·
9 min read
Pharm Country
Olympus Awarded PROVISTA Contract for Advanced Energy Portfolio
Olympus announced that it has been awarded a contract for its advanced energy portfolio by Provista Inc.
March 29, 2024
·
3 min read
Press Releases
University of Texas Permian Basin’s Water In Energy Conference Returns to Midland with Exciting New Opportunities
January 21, 2025
·
2 min read
1 of 2,904
Next
